BIOGEN for BIOGEN
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing The Mental Health Professionals Workforce Shortage Loan Repayment Act S.1214, RARE Act Issues related to ALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| JOHN RAYMOND GIBSON | — |
| TYLER HANSON | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
| ALI LAKHANI | — |
Medicare/Medicaid MMM
Drug cost and pricing policy issues Issues related to the 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
Pharmacy PHA
Drug cost and pricing policy S.1967, PBM Act S.1542, DRUG Act H.R.5539, ORPHAN Cures Act Discussions regarding pharmaceutical issues related to supply chain S.113, Prescription Pricing for the People Act of 2023 H.R.830, HELP Copays Act H.R.485, Protecting Health Care for All Patients Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| AARON NICHOLAS BADIDA | — |
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
| KATHLEEN KONKA | — |
Taxation/Internal Revenue Code TAX
Issues related to tax reform and tax policy Implementation of Tax Cuts and Jobs Act of 2017 (P.L.115-97) American Innovation and Jobs Act Issues related to OECD negotiations on the taxation of global income
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN CAUSEY | — |
| DANIEL HARDER | — |
Trade (domestic/foreign) TRD
Trade-related aspects of Intellectual Property (TRIPS) Waiver, no related bill number
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Copyright/Patent/Trademark CPT
Support stronger IP and exclusivity protections and enforcement in foreign markets
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL HARDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.